Heartflow (NASDAQ:HTFL) CEO John C.M. Farquhar Sells 3,890 Shares

Heartflow, Inc. (NASDAQ:HTFL - Get Free Report) CEO John Farquhar sold 3,890 shares of the firm's stock in a transaction dated Friday, September 11th. The stock was sold at an average price of $50.00, for a total value of $194,500.00. Following the completion of the sale, the chief executive officer directly owned 321,914 shares in the company, valued at approximately $16,095,700. The trade was a 1.19% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

John C.M. Farquhar also recently made the following trade(s):

• On Thursday, September 10th, John Farquhar sold 35,010 shares of Heartflow stock. The shares were sold at an average price of $46.42, for a total transaction of $1,625,164.20.
• On Friday, August 21st, John Farquhar sold 27,230 shares of Heartflow stock. The stock was sold at an average price of $50.00, for a total transaction of $1,361,500.00.
• On Tuesday, August 18th, John Farquhar sold 32,676 shares of Heartflow stock. The stock was sold at an average price of $45.00, for a total transaction of $1,470,420.00.
• On Friday, August 14th, John Farquhar sold 15,560 shares of Heartflow stock. The stock was sold at an average price of $39.06, for a total value of $607,773.60.
• On Monday, August 10th, John Farquhar sold 22,562 shares of Heartflow stock. The shares were sold at an average price of $28.31, for a total value of $638,730.22.
• On Friday, July 10th, John Farquhar sold 22,562 shares of Heartflow stock. The stock was sold at an average price of $27.75, for a total value of $626,095.50.
• On Wednesday, June 24th, John Farquhar sold 38,900 shares of Heartflow stock. The stock was sold at an average price of $35.00, for a total value of $1,361,500.00.

Heartflow Stock Down 0.7%

---

---

Shares of HTFL opened at $49.54 on Tuesday. The business's 50 day moving average is $35.97 and its two-hundred day moving average is $31.03. Heartflow, Inc. has a 52-week low of $20.13 and a 52-week high of $51.78. The firm has a market cap of $4.31 billion and a price-to-earnings ratio of -27.07.

Heartflow (NASDAQ:HTFL - Get Free Report) last released its earnings results on Thursday, August 13th. The company reported ($0.07) earnings per share for the quarter, topping the consensus estimate of ($0.22) by $0.15. Heartflow had a negative net margin of 55.82% and a negative return on equity of 23.52%. The company had revenue of $64.08 million during the quarter. Heartflow's quarterly revenue was up 47.7% on a year-over-year basis. On average, equities analysts expect that Heartflow, Inc. will post -0.75 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Heartflow

Several hedge funds and other institutional investors have recently modified their holdings of HTFL. Engineers Gate Manager LP bought a new stake in shares of Heartflow during the second quarter valued at approximately $590,000. Integrated Wealth Concepts LLC bought a new position in Heartflow in the 2nd quarter worth approximately $53,000. Squarepoint Ops LLC increased its position in Heartflow by 72.0% in the 2nd quarter. Squarepoint Ops LLC now owns 87,052 shares of the company's stock valued at $2,554,000 after acquiring an additional 36,441 shares during the period. Arizona State Retirement System bought a new stake in Heartflow during the 2nd quarter valued at $312,000. Finally, Allianz Asset Management GmbH acquired a new position in Heartflow during the 2nd quarter worth $1,557,000.

Analysts Set New Price Targets

A number of research analysts have commented on HTFL shares. JPMorgan Chase & Co. increased their target price on Heartflow from $35.00 to $45.00 and gave the stock an "overweight" rating in a report on Friday, August 14th. Stifel Nicolaus boosted their price target on Heartflow from $40.00 to $45.00 and gave the company a "buy" rating in a report on Friday, August 14th. Wells Fargo & Company upped their price target on Heartflow from $37.00 to $39.00 and gave the company an "overweight" rating in a research report on Friday, August 14th. UBS Group started coverage on Heartflow in a research note on Wednesday, September 9th. They set a "neutral" rating and a $55.00 price objective on the stock. Finally, Weiss Ratings raised shares of Heartflow from a "sell (e+)" rating to a "sell (d-)" rating in a report on Friday, August 7th. One analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company's stock. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $44.88.

Check Out Our Latest Research Report on HTFL

Heartflow Company Profile

(Get Free Report)

Heartflow, Inc is a medical technology company that develops artificial intelligence and imaging solutions for the diagnosis and management of coronary artery disease. Its platform analyzes data from coronary computed tomography angiography (CCTA) scans to create personalized, three-dimensional models of a patient's coronary arteries.

The company's primary offering, Heartflow Analysis, is designed to provide noninvasive estimates of fractional flow reserve derived from computed tomography (FFR^CT).

Recommended Stories

• Five stocks we like better than Heartflow
• Analysts Are Punting Their Calls Into the Next Quarter After Adobe’s Mixed Earnings
• Institutional Money Is Pouring Into These 2 Altcoin ETFs
• The End of Big Tech Buybacks? Only One Hyperscaler Is Still Repurchasing Shares
• 3 Dividend Kings to Buy While They’re Still Beaten Down

This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].